Skip to Main Content

Browse issues

Volume 50, Issue 5, May 2020

Review

Fuyuhiko Motoi and Michiaki Unno
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 483–489, https://doi.org/10.1093/jjco/hyaa018

Progress of adjuvant therapy for pancreatic cancer has improved post-resection survival. Recent randomized trials showed the superiority of neoadjuvant therapy versus up-front surgery on survival following planned pancreatic cancer resection.

Jun Itami
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 490–501, https://doi.org/10.1093/jjco/hyaa029

Brachytherapy is the utmost precision radiation therapy even surpassing the most modern carbon ion therapy in dose distribution.

Hidehito Horinouchi and Yuichiro Ohe
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 502–511, https://doi.org/10.1093/jjco/hyaa031

An overview of all studies conducted by the Japan Clinical Oncology Group Lung Cancer Study Group from 1970s to 2019.

Original Articles

Diagnostic Radiology

Yasuji Miyakita and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 512–518, https://doi.org/10.1093/jjco/hyaa010

Carbon-11-labeled methionine positron-emission tomography can accurately assess the treatment response of primary central nervous system lymphoma, which is often difficult to assess using magnetic resonance images alone.

Epidemiology/Public Health

Kyoko Matsukawa and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 519–527, https://doi.org/10.1093/jjco/hyaa027

For the first time in Japan, health-related quality of life using Expanded Prostate Cancer Index Composite questionnaires in Japanese patients with prostate cancer after proton beam therapy was investigated and compared with other treatment modalities.

Gastrointestinal Medicine

Masanori Terashima and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 528–534, https://doi.org/10.1093/jjco/hyaa005

GI Surgery

Renjie Wang and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 535–542, https://doi.org/10.1093/jjco/hyaa011

This study confirmed the safety of using carbon nanoparticles suspension as a tracer in colorectal cancer, which could significantly increase the detected number of lymph nodes in colorectal cancer.

Gynecology

Shinichi Togami and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 543–547, https://doi.org/10.1093/jjco/hyaa001

Sentinel node navigation surgery, not pelvic lymphadenectomy, is the best treatment option for preventing the development of lower extremity lymphedema and pelvic lymphocele in cervical cancer patients.

Head & Neck

Xiang Zheng and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 548–555, https://doi.org/10.1093/jjco/hyaa002

Different radio-insensitive NPC xenografts underwent radiotherapy. DKI-MRI and tumour histopathological biomarkers were used to evaluate the abilities of them in monitoring the responses of NPC xenografts to radiotherapy.

Hepato-biliary and Pancreatic Surgery

Dong Zeng and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 556–567, https://doi.org/10.1093/jjco/hyaa017

We carried out a systematic review of primary hepatic angiosarcoma and highlighted the use of routine physical examinations and surgery combined with adjuvant chemotherapy to improve the outcomes.

Orthopedics/Sarcoma

Tomoya Matsunobu and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 568–573, https://doi.org/10.1093/jjco/hyaa007

A systematic review to assess the effectiveness and safety of radiotherapy for desmoid tumors revealed that radiotherapy was valuable in controlling local lesions while the occurrence of developing late toxicities should be considered.

Munehisa Kito and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 574–580, https://doi.org/10.1093/jjco/hyaa009

Non-surgical treatment might be appropriate for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis when considering the exacerbation rate and treatment-associated complications.

Palliative and Supportive Care

Yehuan Liu and Beibei Lin
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 581–585, https://doi.org/10.1093/jjco/hyz214

We used the QCC method to improve the management of cancer pain, and the results showed that cancer pain was well controlled.

Yoshinobu Matsuda and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 586–593, https://doi.org/10.1093/jjco/hyaa003

The Japanese Psycho-Oncology Society and Japanese Association of Supportive Care in Cancer launched the guidelines for delirium. This article reports the process of developing the guideline and summarizes the recommendations.

Thoracic Medicine

Jiyun Lee and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 594–601, https://doi.org/10.1093/jjco/hyaa019

The incidence of intracranial metastases for rearranged during transfection-rearranged non-small cell lung cancer was 44%, while the intracranial efficacy of rearranged during transfection inhibitors remains insufficient. Development of a novel tyrosine kinase inhibitor with higher RET selectivity and blood–brain barrier penetration is warranted.

Thoracic Surgery

Jun Chi and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 602–608, https://doi.org/10.1093/jjco/hyz212

Without related complications, EBUS-TBNA give a sensitivity of 88.9% with an overall diagnostic accuracy of 90.0% and is a safe and effective approach for suspected recurrent intrathoracic masses after esophagectomy.

Urology

Haruka Miyata and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 609–616, https://doi.org/10.1093/jjco/hyz211

This study reported outcomes of the treatment with a real-time tumor-tracking radiotherapy system. This therapy is an alternative for patients that are medically unfit for or do not want to undergo cystectomy.

Short Communication

Eriko Miyawaki and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 617–622, https://doi.org/10.1093/jjco/hyaa033

In this retrospective study, a programmed death-ligand 1 (PD-L1) tumor proportion score ≥ 50% was significantly more frequent in non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor (EGFR) mutations and was positively associated with pembrolizumab efficacy.

Image of the Month

Sunao Uemura and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 623–625, https://doi.org/10.1093/jjco/hyz184

Cancer Statistics Digest

Tomohiro Matsuda and Kumiko Saika
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 626–627, https://doi.org/10.1093/jjco/hyaa057
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close